Immune dysfunction and neuroinflammation in autism spectrum disorder.

Autism spectrum disorder (ASD) is a complex heterogeneous neurodevelopmental disorder with a complex pathogenesis. Many studies over the last four decades have recognized altered immune responses among individuals diagnosed with ASD. The purpose of this critical and comprehensive review is to examine the hypothesis that immune dysfunction is present more frequently, and it is related to ASD in humans. It was found that that often individuals diagnosed with ASD have alterations in immune cells such as T cells, B cells, monocytes, natural killer cells, and dendritic cells. Also, many individuals diagnosed with ASD have alterations in immunoglobulins and increased autoantibodies. Finally, an important portion of individuals diagnosed with ASD has elevated peripheral cytokines and chemokines and associated neuroinflammation. In conclusion, immune dysregulation and inflammation are important components of ASD diagnosis and are key components of the diagnosis and treatment of ASD.

[1]  K. Coleman,et al.  Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: A preliminary report , 2013, Brain, Behavior, and Immunity.

[2]  Martyn A. Sharpe,et al.  B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal , 2013, Journal of toxicology.

[3]  D. Kaufer,et al.  A potential role for glia‐derived extracellular matrix remodeling in postinjury epilepsy , 2016, Journal of neuroscience research.

[4]  L. Al-Ayadhi,et al.  Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children , 2013, Journal of Neuroinflammation.

[5]  E. Bosmans,et al.  Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder. , 2016, In vivo.

[6]  Elena L. Grigorenko,et al.  Macrophage Migration Inhibitory Factor and Autism Spectrum Disorders , 2008, Pediatrics.

[7]  Altered Cytokine and BDNF Levels in Autism Spectrum Disorder , 2013, Neurotoxicity Research.

[8]  T. Theoharides Is a subtype of autism an allergy of the brain? , 2013, Clinical therapeutics.

[9]  I. Hertz-Picciotto,et al.  Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms , 2008, Autism research : official journal of the International Society for Autism Research.

[10]  D. Rossignol Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. , 2007, Medical hypotheses.

[11]  Sudhir Gupta,et al.  Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics , 1996, Journal of autism and developmental disorders.

[12]  G. Mostafa,et al.  Frequency of CD4+CD25high Regulatory T Cells in the Peripheral Blood of Egyptian Children With Autism , 2010, Journal of child neurology.

[13]  Jie-ru Zhou,et al.  The microbiota–gut–brain axis and its potential therapeutic role in autism spectrum disorder , 2016, Neuroscience.

[14]  Geir Bjorklund,et al.  Evaluation of whole blood zinc and copper levels in children with autism spectrum disorder , 2016, Metabolic Brain Disease.

[15]  E. Courchesne,et al.  Microglial Activation and Increased Microglial Density Observed in the Dorsolateral Prefrontal Cortex in Autism , 2010, Biological Psychiatry.

[16]  R. Steinman Dendritic cells: versatile controllers of the immune system , 2007, Nature Medicine.

[17]  Hyunju Kim,et al.  The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring , 2016, Science.

[18]  Jaquelyn B. McCandless,et al.  Low natural killer cell cytotoxic activity in autism: The role of glutathione, IL-2 and IL-15 , 2008, Journal of Neuroimmunology.

[19]  S. Abd El-Nabi,et al.  The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders , 2017 .

[20]  E. Bosmans,et al.  Activation of the Inflammatory Response System in Autism , 2002, Neuropsychobiology.

[21]  D. Streck,et al.  Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study , 2012, Journal of Neuroinflammation.

[22]  N. J. Allen,et al.  Role of astrocyte–synapse interactions in CNS disorders , 2017, The Journal of physiology.

[23]  C. Carcassi,et al.  Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers , 2014, Brain, Behavior, and Immunity.

[24]  H. Jyonouchi,et al.  Dysregulated Innate Immune Responses in Young Children with Autism Spectrum Disorders: Their Relationship to Gastrointestinal Symptoms and Dietary Intervention , 2005, Neuropsychobiology.

[25]  P. Ashwood,et al.  Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. , 2013, Neurotoxicology and teratology.

[26]  T. Bale,et al.  Alterations in the Vaginal Microbiome by Maternal Stress Are Associated With Metabolic Reprogramming of the Offspring Gut and Brain. , 2015, Endocrinology.

[27]  Ugis Sarkans,et al.  Biomarkers in autism spectrum disorder: the old and the new , 2014, Psychopharmacology.

[28]  K. Alysandratos,et al.  Mast cell activation and autism. , 2012, Biochimica et biophysica acta.

[29]  P. Ashwood,et al.  Spontaneous Mucosal Lymphocyte Cytokine Profiles in Children with Autism and Gastrointestinal Symptoms: Mucosal Immune Activation and Reduced Counter Regulatory Interleukin-10 , 2004, Journal of Clinical Immunology.

[30]  Geir Bjorklund,et al.  Acid glycosaminoglycan (aGAG) excretion is increased in children with autism spectrum disorder, and it can be controlled by diet , 2015, Metabolic Brain Disease.

[31]  Jolanta Wasilewska,et al.  Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old , 2012, Archives of medical science : AMS.

[32]  A. Davidow,et al.  Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype? , 2014, Journal of Neuroinflammation.

[33]  L. Al-Ayadhi,et al.  Elevated serum levels of interleukin-17A in children with autism , 2012, Journal of Neuroinflammation.

[34]  M. Hadders‐Algra,et al.  Minor neurological dysfunction in children with autism spectrum disorder , 2011, Developmental medicine and child neurology.

[35]  Helen Barbas,et al.  Altered neural connectivity in excitatory and inhibitory cortical circuits in autism , 2013, Front. Hum. Neurosci..

[36]  V. Singh,et al.  Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. , 1990, Immunological investigations.

[37]  J. Belmont,et al.  Nutritional and Metabolic Biomarkers in Autism Spectrum Disorders: An Exploratory Study. , 2015, Integrative medicine.

[38]  V. Lakshminarayanan,et al.  Visual function in autism spectrum disorders: a critical review , 2016, Clinical & experimental optometry.

[39]  H. Ueno,et al.  Dendritic cell subsets in health and disease , 2007, Immunological reviews.

[40]  Xiaohong Li,et al.  Inflammatory Cytokines: Potential Biomarkers of Immunologic Dysfunction in Autism Spectrum Disorders , 2015, Mediators of inflammation.

[41]  L. Lee,et al.  Maternal antibrain antibodies in autism , 2007, Brain, Behavior, and Immunity.

[42]  Jillian M. Saffin,et al.  Walk like me, talk like me , 2016, Neurosciences.

[43]  Geir Bjorklund,et al.  The levels of blood mercury and inflammatory-related neuropeptides in the serum are correlated in children with autism spectrum disorder , 2016, Metabolic Brain Disease.

[44]  H. Wei,et al.  Brain IL-6 and autism , 2013, Neuroscience.

[45]  D. Amaral,et al.  Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors , 2013, Brain, Behavior, and Immunity.

[46]  A. Guastella,et al.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis , 2014, Molecular Psychiatry.

[47]  Y. Nakagawa,et al.  Involvement of Neuroinflammation during Brain Development in Social Cognitive Deficits in Autism Spectrum Disorder and Schizophrenia , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[48]  D. Siniscalco,et al.  The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages , 2014, Journal of Neuroinflammation.

[49]  Sangita B. Patil,et al.  Elevated immune response in the brain of autistic patients , 2009, Journal of Neuroimmunology.

[50]  Károly Mirnics,et al.  Immune transcriptome alterations in the temporal cortex of subjects with autism , 2008, Neurobiology of Disease.

[51]  Jin-gang Fan,et al.  High plasma neopterin levels in Chinese children with autism spectrum disorders , 2015, International Journal of Developmental Neuroscience.

[52]  W. Grant,et al.  What is the role of vitamin D in autism? , 2013, Dermato-endocrinology.

[53]  Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study , 2014, Journal of Neuroinflammation.

[54]  Paula Krakowiak,et al.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome , 2011, Brain, Behavior, and Immunity.

[55]  Cathleen K. Yoshida,et al.  Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study , 2011, Molecular autism.

[56]  R Day,et al.  Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism , 2002, Molecular Psychiatry.

[57]  T. Savidge,et al.  The Brain-Gut-Microbiome Axis: What Role Does it Play in Autism Spectrum Disorder? , 2016, Current Developmental Disorders Reports.

[58]  R Day,et al.  Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. , 2001, The Journal of pediatrics.

[59]  J. Kern,et al.  Medical conditions in autism and events associated with the initial onset of autism , 2014 .

[60]  Takeo Fujiwara,et al.  Chemicals, Nutrition, and Autism Spectrum Disorder: A Mini-Review , 2016, Front. Neurosci..

[61]  Jie Yang,et al.  Action observation and imitation in autism spectrum disorders: an ALE meta-analysis of fMRI studies , 2015, Brain Imaging and Behavior.

[62]  Mohammad Wahid Ansari,et al.  The legal status of in vitro embryos , 2014 .

[63]  E. Aronica,et al.  Interleukin-18 modulation in autism spectrum disorders , 2016, Journal of Neuroinflammation.

[64]  H. Matsuzaki,et al.  Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[65]  Lam Son Nguyen,et al.  Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiology , 2016, Molecular Autism.

[66]  S. Baron-Cohen,et al.  The Empathy Quotient: An Investigation of Adults with Asperger Syndrome or High Functioning Autism, and Normal Sex Differences , 2004, Journal of autism and developmental disorders.

[67]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[68]  Geir Bjorklund,et al.  Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children , 2016, Nutritional neuroscience.

[69]  Tian-tian Wang,et al.  [Research advances in immunological dysfunction in children with autism spectrum disorders]. , 2014, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[70]  Geir Bjorklund,et al.  The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas , 2016, Metabolic Brain Disease.

[71]  Patricia Howlin,et al.  Outcome in High-Functioning Adults with Autism with and Without Early Language Delays: Implications for the Differentiation Between Autism and Asperger Syndrome , 2003, Journal of autism and developmental disorders.

[72]  A. McAllister,et al.  Immune mediators in the brain and peripheral tissues in autism spectrum disorder , 2015, Nature Reviews Neuroscience.

[73]  L. Al-Ayadhi,et al.  A possible association between elevated serum levels of brain-specific auto-antibodies and reduced plasma levels of docosahexaenoic acid in autistic children , 2015, Journal of Neuroimmunology.

[74]  Jareen Meinzen-Derr,et al.  Elevated cytokine levels in children with autism spectrum disorder , 2006, Journal of Neuroimmunology.

[75]  Gehan A. Mostafa,et al.  Antineuronal antibodies in autistic children: relation to blood mercury , 2007 .

[76]  E. Demirci,et al.  Lack of serum antineuronal antibodies in children with autism. , 2016, Bratislavske lekarske listy.

[77]  I. Koch,et al.  Intact mirror mechanisms for automatic facial emotions in children and adolescents with autism spectrum disorder , 2017, Autism research : official journal of the International Society for Autism Research.

[78]  Wonsuk Yoo,et al.  Autism spectrum disorders are associated with an elevated autoantibody response to tissue transglutaminase‐2 , 2011, Autism research : official journal of the International Society for Autism Research.

[79]  L. Al-Ayadhi,et al.  Brain autoantibodies in autism spectrum disorder. , 2014, Biomarkers in medicine.

[80]  E. Hsiao Immune dysregulation in autism spectrum disorder. , 2013, International review of neurobiology.

[81]  C. Pantelis,et al.  Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD , 2015, Neuroscience & Biobehavioral Reviews.

[82]  K. Takeda,et al.  Microbial and dietary factors modulating intestinal regulatory T cell homeostasis , 2014, FEBS letters.

[83]  Taylor L. Gist,et al.  Alterations in Sensitivity to Estrogen, Dihydrotestosterone, and Xenogens in B-Lymphocytes from Children with Autism Spectrum Disorder and Their Unaffected Twins/Siblings , 2013, Journal of toxicology.

[84]  H. Shiraha,et al.  Serum levels of platelet‐derived growth factor‐BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure , 2011, Journal of gastroenterology and hepatology.

[85]  Janet K. Kern,et al.  Evidence of microglial activation in autism and its possible role in brain underconnectivity , 2011, Neuron glia biology.

[86]  H. Hou,et al.  Aberrant T‐lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein‐α: implications for autism , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[87]  H. Barbas,et al.  Changes in Prefrontal Axons May Disrupt the Network in Autism , 2010, The Journal of Neuroscience.

[88]  S. Baron-Cohen,et al.  From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition , 2016, Molecular Autism.

[89]  V. Singh,et al.  CD4+ helper T cell depression in autism. , 1990, Immunology letters.

[90]  M. Posada,et al.  Characterization of immune cell phenotypes in adults with autism spectrum disorders , 2016, Journal of Investigative Medicine.

[91]  L. Al-Ayadhi,et al.  Systemic auto-antibodies in children with autism , 2014, Journal of Neuroimmunology.

[92]  N. M. Lau,et al.  Markers of Celiac Disease and Gluten Sensitivity in Children with Autism , 2013, PloS one.

[93]  D. Ostatníková,et al.  Synapse alterations in autism: Review of animal model findings. , 2016, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[94]  S. Mazmanian,et al.  Modeling an autism risk factor in mice leads to permanent immune dysregulation , 2012, Proceedings of the National Academy of Sciences.

[95]  M. Butler,et al.  Plasma cytokine levels in children with autistic disorder and unrelated siblings , 2012, International Journal of Developmental Neuroscience.

[96]  Junko Matsuzaki,et al.  Retrospective diagnosis of congenital cytomegalovirus infection in children with autism spectrum disorder but no other major neurologic deficit , 2015, Brain and Development.

[97]  Sudhir Gupta,et al.  Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism , 1998, Journal of Neuroimmunology.

[98]  C. McDougle,et al.  High blood monocyte counts and neopterin levels in children with autistic disorder. , 2003, The American journal of psychiatry.

[99]  M. Salti,et al.  Mirror Neurons and Mirror-Touch Synesthesia , 2017, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[100]  R. Gambari,et al.  Cytokines profile and peripheral blood mononuclear cells morphology in Rett and autistic patients. , 2016, Cytokine.

[101]  C. Tinelli,et al.  An Autistic Endophenotype Results in Complex Immune Dysfunction in Healthy Siblings of Autistic Children , 2009, Biological Psychiatry.

[102]  D. Siniscalco Commentary: The Impact of Neuroimmune Alterations in Autism Spectrum Disorder , 2015, Front. Psychiatry.

[103]  Yingying Ding,et al.  Family history of autoimmune diseases is associated with an increased risk of autism in children: A systematic review and meta-analysis , 2015, Neuroscience & Biobehavioral Reviews.

[104]  D. Amaral,et al.  Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders , 2013, Molecular Autism.

[105]  Cathleen K. Yoshida,et al.  Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study , 2016, Translational Psychiatry.

[106]  P. Ashwood,et al.  The role of immune dysfunction in the pathophysiology of autism , 2012, Brain, Behavior, and Immunity.

[107]  R. Neuman,et al.  Brain-Derived Neurotrophic Factor and Autoantibodies to Neural Antigens in Sera of Children with Autistic Spectrum Disorders, Landau-Kleffner Syndrome, and Epilepsy , 2006, Biological Psychiatry.

[108]  C. Gottfried,et al.  The Impact of Neuroimmune Alterations in Autism Spectrum Disorder , 2015, Front. Psychiatry.

[109]  D. Denney,et al.  Lymphocyte subsets and interleukin-2 receptors in autistic children , 1996, Journal of autism and developmental disorders.

[110]  E. Bosmans,et al.  Increased serum albumin, γ globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism , 2002, Psychological Medicine.

[111]  Alan S. Brown,et al.  Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[112]  G. Stubbs Interferonemia and autism. , 1995, Journal of autism and developmental disorders.

[113]  P. Ashwood,et al.  The immune response in autism: a new frontier for autism research , 2006, Journal of leukocyte biology.

[114]  A. Nadeem,et al.  Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism , 2016, Molecular Neurobiology.

[115]  V. Napolioni,et al.  Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder , 2014, Brain, Behavior, and Immunity.

[116]  P. Ashwood,et al.  Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction , 2012, Journal of Neuroimmunology.

[117]  D. Amaral,et al.  Immune Endophenotypes in Children With Autism Spectrum Disorder , 2017, Biological Psychiatry.

[118]  Cathleen K. Yoshida,et al.  Maternal Mid-Pregnancy Autoantibodies to Fetal Brain Protein: The Early Markers for Autism Study , 2008, Biological Psychiatry.

[119]  D. Amaral,et al.  Autoantibodies in Autism Spectrum Disorders (ASD) , 2007, Annals of the New York Academy of Sciences.

[120]  Geir Bjorklund,et al.  The role of zinc and copper in autism spectrum disorders. , 2013, Acta neurobiologiae experimentalis.

[121]  S. Deaglio,et al.  CD38 and CD157 as Receptors of the Immune System: A Bridge Between Innate and Adaptive Immunity , 2006, Molecular medicine.

[122]  V. Singh,et al.  Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism , 1996, Journal of Neuroimmunology.

[123]  L. Al-Ayadhi,et al.  The Possible Association between Elevated Levels of Blood Mercury and the Increased Frequency of Serum Anti-myelin Basic Protein Auto-antibodies in Autistic Children , 2015 .

[124]  A. McAllister,et al.  Maternal TH17 cells take a toll on baby's brain , 2016, Science.

[125]  J. Gregg,et al.  Altered gene expression and function of peripheral blood natural killer cells in children with autism , 2009, Brain, Behavior, and Immunity.

[126]  I. Hertz-Picciotto,et al.  Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder , 2017, Biological Psychiatry.

[127]  M. Codagnone,et al.  Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism , 2015, Developmental Neuroscience.

[128]  I. Hertz-Picciotto,et al.  Altered T cell responses in children with autism , 2011, Brain, Behavior, and Immunity.

[129]  N. Meguid,et al.  Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder , 2016, Metabolic Brain Disease.

[130]  I. Hertz-Picciotto,et al.  Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma , 2015, Journal of Neuroimmunology.

[131]  P. Nafstad [Atopic diseases]. , 2000, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[132]  K. Żwirska-Korczala,et al.  Neopterin measurement in clinical diagnosis , 2001, Journal of clinical pharmacy and therapeutics.

[133]  H. Savelkoul,et al.  Immune dysregulation in autism spectrum disorder , 2013, European Journal of Pediatrics.

[134]  Alexander B Poletaev,et al.  Adaptive Maternal Immune Deviations as a Ground For Autism Spectrum Disorders Development in Children , 2014, Folia medica.

[135]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[136]  L. Al-Ayadhi,et al.  Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: Relation to autoimmunity , 2012, Journal of Neuroinflammation.

[137]  I. Hertz-Picciotto,et al.  Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders , 2011, Journal of Neuroimmunology.

[138]  D. Amaral,et al.  In Search of Cellular Immunophenotypes in the Blood of Children with Autism , 2011, PloS one.

[139]  R. Doyle,et al.  Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders , 2016, Translational Psychiatry.

[140]  T. Nakayama,et al.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. , 2016, International immunology.

[141]  P. Ashwood,et al.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders , 2010, Brain, Behavior, and Immunity.

[142]  K. Francis,et al.  Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism , 2014, Translational Psychiatry.

[143]  Geir Bjorklund,et al.  Serum copper and zinc levels in individuals with autism spectrum disorders , 2014, Neuroreport.

[144]  P. Ashwood,et al.  Brain‐Specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder , 2007, Annals of the New York Academy of Sciences.

[145]  P. Ashwood,et al.  Evidence supporting an altered immune response in ASD. , 2015, Immunology letters.

[146]  Geir Bjørklund,et al.  Levels of Metals in the Blood and Specific Porphyrins in the Urine in Children with Autism Spectrum Disorders , 2014, Biological Trace Element Research.

[147]  J. Bressler,et al.  Maternal antibody reactivity to lymphocytes of offspring with autism. , 2012, Pediatric neurology.

[148]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.